Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

The effect of respiratory viruses on immunogenicity and protection induced by a candidate universal influenza vaccine in mice.

Rowell J, Lo CY, Price GE, Misplon JA, Crim RL, Jayanti P, Beeler J, Epstein SL.

PLoS One. 2019 Apr 15;14(4):e0215321. doi: 10.1371/journal.pone.0215321. eCollection 2019.

2.

Development of Luciferase Immunoprecipitation Systems (LIPS) Assay to Detect IgG Antibodies against Human Respiratory Syncytial Virus G-Glycoprotein.

Crim RL, Kumari S, Jayanti P, Audet S, Kulkarni A, Beeler J.

Vaccines (Basel). 2019 Feb 1;7(1). pii: E16. doi: 10.3390/vaccines7010016.

3.

Correction for Kim et al., development of an adenovirus-based respiratory syncytial virus vaccine: preclinical evaluation of efficacy, immunogenicity, and enhanced disease in a cotton rat model.

Kim E, Okada K, Beeler JA, Crim RL, Steitz J, Piedra PA, Gilbert BE, Gambotto A.

J Virol. 2015 May;89(9):5193. doi: 10.1128/JVI.03669-14. No abstract available.

4.

Development of an adenovirus-based respiratory syncytial virus vaccine: preclinical evaluation of efficacy, immunogenicity, and enhanced disease in a cotton rat model.

Kim E, Okada K, Beeler JA, Crim RL, Piedra PA, Gilbert BE, Gambotto A.

J Virol. 2014 May;88(9):5100-8. doi: 10.1128/JVI.03194-13. Epub 2014 Feb 26. Erratum in: J Virol. 2015 May;89(9):5193.

5.

Development of a luciferase immunoprecipitation system assay to detect IgG antibodies against human respiratory syncytial virus nucleoprotein.

Kumari S, Crim RL, Kulkarni A, Audet SA, Mdluli T, Murata H, Beeler JA.

Clin Vaccine Immunol. 2014 Mar;21(3):383-90. doi: 10.1128/CVI.00594-13. Epub 2014 Jan 8.

6.

A neutralization assay for respiratory syncytial virus using a quantitative PCR-based endpoint assessment.

Varada JC, Teferedegne B, Crim RL, Mdluli T, Audet S, Peden K, Beeler J, Murata H.

Virol J. 2013 Jun 15;10:195. doi: 10.1186/1743-422X-10-195.

7.
8.

Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity.

Crim RL, Audet SA, Feldman SA, Mostowski HS, Beeler JA.

J Virol. 2007 Jan;81(1):261-71. Epub 2006 Oct 18.

9.

Human respiratory syncytial virus surface glycoproteins F, G and SH form an oligomeric complex.

Feldman SA, Crim RL, Audet SA, Beeler JA.

Arch Virol. 2001 Dec;146(12):2369-83.

PMID:
11811686
10.

Evaluation of vaccines, interferons and cell substrates for pestivirus contamination.

Audet SA, Crim RL, Beeler J.

Biologicals. 2000 Mar;28(1):41-6.

PMID:
10799055

Supplemental Content

Support Center